➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKesson
Medtronic
Mallinckrodt
McKinsey

Last Updated: October 29, 2020

DrugPatentWatch Database Preview

Perphenazine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for perphenazine and what is the scope of patent protection?

Perphenazine is the generic ingredient in two branded drugs marketed by Pharm Assoc, Schering, Ani Pharms Inc, Mylan, Rising, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, and Zydus Pharms, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for perphenazine. Thirteen suppliers are listed for this compound.

Drug Prices for perphenazine

See drug prices for perphenazine

Recent Clinical Trials for perphenazine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lindner Center of HOPEPhase 2
Centre for Addiction and Mental HealthPhase 4
Janssen Scientific Affairs, LLCPhase 3

See all perphenazine clinical trials

Pharmacology for perphenazine
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for perphenazine

US Patents and Regulatory Information for perphenazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc PERPHENAZINE perphenazine TABLET;ORAL 089456-001 Sep 10, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms PERPHENAZINE perphenazine TABLET;ORAL 205232-002 Apr 6, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc PERPHENAZINE perphenazine TABLET;ORAL 207582-001 Oct 17, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Rising PERPHENAZINE perphenazine TABLET;ORAL 205056-002 Mar 1, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Johnson and Johnson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.